BeiGene, Ltd is a global oncology company that focuses on developing innovative product candidates for cancer treatment and providing high-quality medicines. They have developed the medicine BRUKINSA, approved in more than 60 countries and regions. BeiGene is committed to partnering with academia, biotech, and pharma to bring innovative therapies to more people. They have a global clinical leadership and a science- and medical-based commercial team, with a strong focus on the large and growing market in China.
Headquarters
No. 30, Science Park Road, Zhongguancun Life Science Park, Changping District, Beijing
Beijing; Beijing;
Postal Code: 102206
Contact Details: Purchase the Beone Medicines Ltd. (百济神州有限公司) report to view the information.
Website: http://www.beigene.cn
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS service
To view more information, Request a demonstration of the EMIS service